Healthcare IT

The H1 2026 Healthcare IT PE Update highlights recent PE deal activity and dominant trends in healthcare IT.

This analyst note examines how agentic AI and increasing competition are disrupting the RCM market, threatening PE investment returns as cost-to-collect rates compress and EHR-native rivals expand.

The H2 2025 Healthcare IT PE Update highlights recent PE deal activity and dominant trends in healthcare IT.

The 2025 US Private Equity Momentum Report tracks new PE investments and exits across eight of the largest areas of the US economy covered by PitchBook’s research analysts.

Our 2026 Industry PE Outlook forecasts trends that will shape PE-backed industries in the upcoming year.

AI infrastructure and healthcare sectors are notably active.

The H1 2025 Healthcare IT PE Update highlights recent PE deal activity in the healthcare IT space and discusses the subsector’s dominant trends.

The Q4 2024 Healthcare IT PE Update highlights recent PE deal activity in the healthcare IT space and discusses the subsector’s dominant trends.

The Q3 2024 Healthcare IT VC Update examines the recent trends in healthcare IT VC dealmaking and highlights the top deals in the quarter.

The Q3 2024 Healthcare IT PE Update highlights recent PE deal activity in the healthcare IT space and discusses the subsector’s dominant trends.

Our Digital Health & Healthcare IT Public Comp Sheet and Valuation Guide tracks stock performance, valuations, and market caps of key publicly traded digital health & healthcare IT companies.

The Q2 2024 Healthcare IT VC Update examines the recent trends in healthcare IT VC dealmaking and highlights the top deals in the quarter.

The Q2 2024 Healthcare IT Report provides in-depth analysis of industry trends and evolving PE investment strategies, including deals data and maps of key PE-backed companies and investors.

Healthcare specialist funds of recent vintages performed on par with PE funds investing in other strategies.

The Q1 2024 Healthcare IT Report provides an overview of industry trends and includes market maps of leading VC- and PE-backed companies in the space.

This analyst note shares our thoughts on the key themes that emerged from the J.P. Morgan Healthcare Conference held in January and why they matter for healthcare PE and VC investing.

This analyst note sketches out potential short- and long-term implications of the rise of weight loss drugs on the VC and PE healthcare ecosystems.

Lower credit ratings and dissolved deals are symptoms of an outsized dealmaking slowdown in healthcare and adjacent industries.